Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Optimization of M3 Antagonist-PDE4 Inhibitor (MAPI) Dual Pharmacology Molecules for the Treatment of COPD.
Rizzi A, Amari G, Pivetti F, Delcanale M, Amadei F, Pappani A, Fornasari L, Villetti G, Marchini G, Pisano AR, Pitozzi V, Pittelli MG, Trevisani M, Salvadori M, Cenacchi V, Fioni A, Puccini P, Civelli M, Patacchini R, Baker-Glenn C, Van de Poël H, Blackaby W, Nash K, Armani E. Rizzi A, et al. Among authors: pappani a. J Med Chem. 2023 Aug 24;66(16):11476-11497. doi: 10.1021/acs.jmedchem.3c01012. Epub 2023 Aug 10. J Med Chem. 2023. PMID: 37561958
Discovery and Optimization of Thiazolidinyl and Pyrrolidinyl Derivatives as Inhaled PDE4 Inhibitors for Respiratory Diseases.
Carzaniga L, Amari G, Rizzi A, Capaldi C, De Fanti R, Ghidini E, Villetti G, Carnini C, Moretto N, Facchinetti F, Caruso P, Marchini G, Battipaglia L, Patacchini R, Cenacchi V, Volta R, Amadei F, Pappani A, Capacchi S, Bagnacani V, Delcanale M, Puccini P, Catinella S, Civelli M, Armani E. Carzaniga L, et al. Among authors: pappani a. J Med Chem. 2017 Dec 28;60(24):10026-10046. doi: 10.1021/acs.jmedchem.7b01044. Epub 2017 Dec 14. J Med Chem. 2017. PMID: 29200281
Discovery of M3 Antagonist-PDE4 Inhibitor Dual Pharmacology Molecules for the Treatment of Chronic Obstructive Pulmonary Disease.
Armani E, Rizzi A, Capaldi C, De Fanti R, Delcanale M, Villetti G, Marchini G, Pisano AR, Pitozzi V, Pittelli MG, Trevisani M, Salvadori M, Cenacchi V, Puccini P, Amadei F, Pappani A, Civelli M, Patacchini R, Baker-Glenn CAG, Van de Poël H, Blackaby WP, Nash K, Amari G. Armani E, et al. Among authors: pappani a. J Med Chem. 2021 Jul 8;64(13):9100-9119. doi: 10.1021/acs.jmedchem.1c00204. Epub 2021 Jun 18. J Med Chem. 2021. PMID: 34142835
Discovery of a Potent, Selective, and Orally Bioavailable Tool Compound for Probing the Role of Lysophosphatidic Acid Type 2 Receptor Antagonists in Fibrotic Disorders.
Armani E, Rizzi A, Iotti N, Saccani F, Di Lascia MR, Tigli L, Pappani A, Marchini G, Murgo A, Capelli AM, Delcanale M, Puccini P, Villetti G, Civelli M, Beato C, Giuliani M, Mundi C, Murarolli F, Pagano M, Raveglia LF, Remelli R, Amari G. Armani E, et al. Among authors: pappani a. J Med Chem. 2023 Apr 27;66(8):5622-5656. doi: 10.1021/acs.jmedchem.2c02087. Epub 2023 Apr 5. J Med Chem. 2023. PMID: 37017110
Atropisomerism and Conformational Equilibria: Impact on PI3Kδ Inhibition of 2-((6-Amino-9H-purin-9-yl)methyl)-5-methyl-3-(o-tolyl)quinazolin-4(3H)-one (IC87114) and Its Conformationally Restricted Analogs.
Lodola A, Bertolini S, Biagetti M, Capacchi S, Facchinetti F, Gallo PM, Pappani A, Mor M, Pala D, Rivara S, Visentini F, Corsi M, Capelli AM. Lodola A, et al. Among authors: pappani a. J Med Chem. 2017 May 25;60(10):4304-4315. doi: 10.1021/acs.jmedchem.7b00247. Epub 2017 May 15. J Med Chem. 2017. PMID: 28489362
[Health-related quality of life in patients with chronic kidney disease].
Procaccini DA, Angelini P, Aucella F, Avanzi C, Brusasco S, Carta G, Cataldi G, Cogoni G, D'Agostino F, d'Elia F, Del Mastro G, Dell'aquila R, De Min AM, Feliciangeli G, Freddi P, Gallucci M, Giannico G, Gigante B, Infante B, Ktena M, Manno C, Marseglia CD, Navarra A, Pappani A, Pompa G, Querques M, Russo D, Sacchetti A, Sechi MA, Specchio A, Stallone C, Virgilio M; Apulia Nephrology Quality Of Life Study. Procaccini DA, et al. Among authors: pappani a. G Ital Nefrol. 2008 Nov-Dec;25(6):694-701. G Ital Nefrol. 2008. PMID: 19048570 Italian.
In vitro permeation of levothyroxine across the skin.
Padula C, Pappani A, Santi P. Padula C, et al. Among authors: pappani a. Int J Pharm. 2008 Feb 12;349(1-2):161-5. doi: 10.1016/j.ijpharm.2007.08.004. Epub 2007 Aug 11. Int J Pharm. 2008. PMID: 17931806
Effect of coexistent diseases on survival of patients undergoing dialysis.
Nicolucci A, Cubasso D, Labbrozzi D, Mari E, Impicciatore P, Procaccini DA, Forcella M, Stella I, Querques M, Pappani A, et al. Nicolucci A, et al. Among authors: pappani a. ASAIO J. 1992 Jul-Sep;38(3):M291-5. doi: 10.1097/00002480-199207000-00040. ASAIO J. 1992. PMID: 1457868
HCV infections in dialysis patients.
Scotto G, Savastano AM, Forcella M, Tantimonaco G, Amato G, Salatino G, Pappani A, Stella I. Scotto G, et al. Among authors: pappani a. Nephron. 1992;61(3):320-1. doi: 10.1159/000186922. Nephron. 1992. PMID: 1323780
12 results